AT44289T

Human immune interferon.

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

96 members in 45 offices

This recordMember, by publication datePriority claim35 more offices are in the list below

Priority claims1

Priority claims
Document	Office	Kind	Date
31248981	United States of America	A	1981-10-19

Members96

Family members, oldest first
Document	Office	Kind
IT8223795D0	Italy	D0	1982-10-18
PT75696A	Portugal	A	1982-11-01
IL66992D0	Israel	D0	1983-02-23
IE822517L	Ireland	L	1983-04-19
FI823528L	Finland	L	1983-04-20
NO823467L	Norway	L	1983-04-20
FR2514783A1	France	A1	1983-04-22
EP0077670A2	European Patent Office (EPO)	A2	1983-04-27
AU8935282A	Australia	A	1983-04-28
DE3238554A1	Germany	A1	1983-05-05
GB2107718A	United Kingdom	A	1983-05-05
ZW22282A1	Zimbabwe	A1	1983-05-11
DK460882A	Denmark	A	1983-05-27
JPS5890514A	Japan	A	1983-05-30
PL238671A1	Poland	A1	1983-07-18
BR8206068A	Brazil	A	1983-09-13
ZA827569B	South Africa	B	1983-11-30
ES8402351A1	Spain	A1	1984-02-01
DD208822A5	German Democratic Republic (until 1990)	A5	1984-04-11
GT198277746A	Guatemala	A	1984-04-11
OA07233A	African Intellectual Property Organization (OAPI)	A	1984-04-30
KR840001837A	Republic of Korea	A	1984-06-07
EP0077670A3	European Patent Office (EPO)	A3	1984-07-04
GR78391B	Greece	B	1984-09-27
YU233582A	Yugoslavia, later Serbia and Montenegro (until 2006)	A	1985-03-20
GB2107718B	United Kingdom	B	1985-11-20
FR2514783B1	France	B1	1985-11-29
RO89534A	Romania	A	1986-07-30
IT1153265B	Italy	B	1987-01-14
PT75696B	Portugal	B	1987-03-24
AU561343B2	Australia	B2	1987-05-07
NZ202190A	New Zealand	A	1987-06-30
NZ214261A	New Zealand	A	1987-06-30
DE77670T1	Germany	T1	1987-09-03
JPS62265986A	Japan	A	1987-11-18
BG42527A3	Bulgaria	A3	1987-12-15
CH663619A5	Switzerland	A5	1987-12-31
US4727138A	United States of America	A	1988-02-23
US4762791A	United States of America	A	1988-08-09
BG44877A3	Bulgaria	A3	1989-02-15
SG76988G	Singapore	G	1989-03-23
EP0077670B1	European Patent Office (EPO)	B1	1989-06-28
AT44289TThis record	Austria	T	1989-07-15
JPH0135639B2	Japan	B2	1989-07-26
DE3279788D1	Germany	D1	1989-08-03
HK66289A	Hong Kong, China	A	1989-08-25
IE54371B1	Ireland	B1	1989-09-13
DE3238554C2	Germany	C2	1989-11-23
US4925793A	United States of America	A	1990-05-15
NO164177B	Norway	B	1990-05-28
US4929554A	United States of America	A	1990-05-29
NO164177C	Norway	C	1990-09-12
HU202287B	Hungary	B	1991-02-28
PL153202B1	Poland	B1	1991-03-29
IL66992A	Israel	A	1991-07-18
IL96513A	Israel	A	1991-07-18
IL96513D0	Israel	D0	1991-08-16
JPH03246232A	Japan	A	1991-11-01
PH25922A	Philippines	A	1991-12-19
PH25923A	Philippines	A	1991-12-19
DK163187B	Denmark	B	1992-02-03
US5096705A	United States of America	A	1992-03-17
FI86559B	Finland	B	1992-05-29
DK163187C	Denmark	C	1992-06-22
PH26492A	Philippines	A	1992-07-27
MY102546A	Malaysia	A	1992-07-31
YU45871B	Yugoslavia, later Serbia and Montenegro (until 2006)	B	1992-09-07
FI86559C	Finland	C	1992-09-10
PH26963A	Philippines	A	1992-12-28
MX166499B	Mexico	B	1993-01-12
NL930040I1	Netherlands (Kingdom of the)	I1	1993-08-02
NL930040I2	Netherlands (Kingdom of the)	I2	1993-09-16
MX9206041A	Mexico	A	1994-04-29
LU88327I2	Luxembourg	I2	1994-05-04
NO1994025I1	Norway	I1	1994-12-20
SI8212335A8	Slovenia	A8	1995-10-31
JPH07106144B2	Japan	B2	1995-11-15
RU2056460C1	Russian Federation	C1	1996-03-20
BG60888B2	Bulgaria	B2	1996-05-31
BG60889B2	Bulgaria	B2	1996-05-31
BG60890B2	Bulgaria	B2	1996-05-31
BG60939B2	Bulgaria	B2	1996-06-28
JP2515308B2	Japan	B2	1996-07-10
BG61060B2	Bulgaria	B2	1996-09-30
US5582824A	United States of America	A	1996-12-10
CZ738982A3	Czechia	A3	1997-03-12
CZ282154B6	Czechia	B6	1997-05-14
HRP950157A2	Croatia	A2	1997-08-31
RU2092561C1	Russian Federation	C1	1997-10-10
RU2107728C1	Russian Federation	C1	1998-03-27
SK279535B6	Slovakia	B6	1998-12-02
SK738982A3	Slovakia	A3	1998-12-02
HRP950157B1	Croatia	B1	1999-06-30
DE19375065I2	Germany	I2	2004-07-01
DZ467A1	Algeria	A1	2004-09-13
CA1341590C	Canada	C	2009-02-03

Human immune interferon.

Abstract

Term

Priority claims1

Members96

Numbers

Titles2

Classification